VVC Exploration Corporation (“VVC” or the “Company”) (TSXV:VVC) announces the following
The designation from the FDA has been granted for the company's treatment suvodirsen to treat Duchenne muscular dystrophy.
Picture Genetics will offer three separate screening tests, which will enable individuals to access Fulgent’s advanced genetic testing.
The designation has been given by the US Food and Drug Administration to treat patients with idiopathic pulmonary fibrosis.
The company's initiation of the Phase 2b study follows the positive results reported from a Phase 2a study.
Siyata Mobile will provide a connected communication device, Uniden UV30 for commercial fleets in the United States.
The emissions-certified diesel engines are utilized across wastewater, oil & gas and industrial sectors.